A Natural History Study of Infantile Neuroaxonal Dystrophy

NCT04027816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2022-04-08

No results posted yet for this study

Summary

This study is a longitudinal and prospective study of the natural history of infantile neuroaxonal dystrophy (INAD).

Conditions

  • Neuroaxonal Dystrophy, Infantile

Sponsors & Collaborators

  • Biojiva LLC

    lead INDUSTRY

Principal Investigators

  • Peter Milner, MD · Biojiva LLC

Eligibility

Min Age
18 Months
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2022-02-14
Completion
2022-02-28

Countries

  • China
  • Egypt
  • India
  • Saudi Arabia
  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027816 on ClinicalTrials.gov